AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Dr. Fernandez has disclosed the following relevant financial relationships:
Consultant - Actelion
Speakers Bureau - Bayer
Dr. Oudiz has disclosed the following relevant financial relationships:
Consultant - Actelion, Arena, Bayer, Gilead, United Therapeutics
Contract Research - AADi, Actelion, Arena, Bayer, Gilead, Liquidia, Reata, United Therapeutics
Speakers Bureau - Actelion, Bayer, Gilead, United Therapeutics
Accredited Provider Disclosure
Margaret V. Clark, MSc, RN, RRT - NPS, CMPP, Medical Writer/Interviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Patricia Brignoni, AKH Director of Operations: has disclosed no relevant financial relationships.
Steve Eckert, AKH President & CEO, Planner: has disclosed no relevant financial relationships.
AKH Inc, planners and reviewers have disclosed no financial relationships with pharmaceutical or medical product manufacturers.
This activity is supported by an educational grant from Actelion Pharmaceuticals.
There is no fee to participate in this activity
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.
Copyright © 2018 No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publishe